Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
for
Pancreatic Carcinoma
Location: Boston MA, Baltimore MD, Pittsburgh PA, Atlanta GA,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06271291
Recruiting
Epcoritamab in Previously Treated WM
for
Waldenstrom Macroglobulinemia,
Location: Boston MA, Chapel Hill NC
Sponsor: Gottfried von Keudell, MD PhD
Sex: All
Age: 18+
Code: NCT06510491
Phase 2, Recruiting
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05118789
Phase 1, Phase 2, Recruiting
Precision-Based Genomics in Prostate Cancer
for
Prostate Cancer
Location: Boston MA, New York NY, Bethesda MD, Evanston IL,
Sponsor: National Cancer Institute (NCI)
Sex: Male
Age: 18 - 70+
Code: NCT04706663
Recruiting
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
for
Alopecia Areata
Location: Boston MA, Plymouth Meeting PA, Montreal, Quebec,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07733765
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
for
Advanced Ovarian Carcinoma,
Location: Boston MA, Mineola NY, New York NY, Bethlehem PA,
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT04575935
Phase 3, Recruiting
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Boston MA, New Haven CT, Montreal, Fairfax VA, Toronto,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase 2, Recruiting
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06774963
Phase 1, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Burlington MA, Westbrook ME, New York NY,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Boston MA, Stony Brook NY, Hackensack NJ,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase 3, Recruiting
Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
for
Prostate Cancer (Adenocarcinoma), Prostate Specific Antigen
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: Male
Age: 18+
Code: NCT06862856
Recruiting
A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser
for
Healthy
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06295471
Recruiting
EVOC - EVs in Obesity and Cardiometabolic Disease
for
Cardiovascular Diseases
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06408961
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Boston MA, Montreal, Quebec, Hyattsville MD,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05894239
Phase 3, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Boston MA, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase 1, Phase 2, Recruiting
Advanta VXT and Flixene PMCF Registry
for
Peripheral Arterial Disease
Location: Boston MA
Sponsor: Atrium Medical Corporation
Sex: All
Age: 18+
Code: NCT07161583
Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, New York NY, Philadelphia PA, Madison WI,
Sponsor: Prostate Cancer Clinical Trials Consortium
Sex: Male
Age: 18+
Code: NCT06844383
Phase 2, Recruiting
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
for
Mantle Cell Lymphoma, Lymphoma
Location: Boston MA, New York NY, St Louis MO
Sponsor: Christine Ryan
Sex: All
Age: 18+
Code: NCT06854003
Phase 2, Recruiting
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
for
Relapsed/Refractory Non-Hodgkin Lymphoma
Location: Boston MA, New York NY, Rochester MN, Tampa FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06090539
Phase 1, Phase 2, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company